Psychometric Analysis of the Patient-Reported Hypoparathyroidism Symptom Diary Symptom Subscale Using Data from Two Clinical Trials

Lauren Nelson(RTI Health Solutions), Olulade Ayodele(Takeda (United States)), Jia Ma(RTI Health Solutions), Susan Martin(RTI Health Solutions), Mishaela R. Rubin(Columbia University Irving Medical Center), Steven Ing(The Ohio State University Wexner Medical Center), Rohini Sen(AbbVie (United States))
Patient Related Outcome Measures
November 1, 2023
10.2147/prom.s414794
Cited by 5

Related Papers

Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
|British Journal of Dermatology|2019|384
Characteristics and healthcare costs of patients with fibromyalgia syndrome
|International Journal of Clinical Practice|2007|335
Alendronate in Primary Hyperparathyroidism: A Double-Blind, Randomized, Placebo-Controlled Trial
|The Journal of Clinical Endocrinology & Metabolism|2004|283
Assessing test–retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula
|Quality of Life Research|2018|247
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
|Calcified Tissue International|2019|160